New antifungal drugs--more efficacy or more costs?
Anttila, V.-J.
Duodecim; Laaketieteellinen Aikakauskirja 119(14): 1297-1299
2003
ISSN/ISBN: 0012-7183 PMID: 12916178 Document Number: 558866
Document emailed within 1 workday
Related Documents
Rudofsky, G.; van Laak, H.H. 1994: Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy Journal of Cardiovascular Pharmacology 23(Suppl): S22-S25Yin, K.S. 1984: New antifungal drugs--ketoconazole Zhonghua Nei Ke Za Zhi 23(10): 643-645
Polak, A. 1988: Combination therapy with antifungal drugs Mycoses 31(Suppl): 45-53
Grigoriu, D. 1977: Current antifungal drugs. Superficial mycoses Schweizerische Rundschau für Medizin Praxis 66(28): 871-874
Fara, G.M. 1979: Rational use of antifungal drugs in deep mycoses Progress in Clinical and Biological Research 35: 195-202
Baran, R.; Gupta, A.K. 2002: Are boosters or supplementation of antifungal drugs of any use for treating onychomycosis? Journal of Drugs in Dermatology: Jdd 1(1): 35-41
Tod, M. 2006: Pharmacokinetic of antifungal drugs in order to optimize their administration Therapie 61(3): 219-225
Jullien, V.; Lortholary, O. 2006: Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring Therapie 61(3): 209-217
Schäfer-Korting, M. 2003: New systemic antifungal drugs: mechanisms of action, drug interactions and side effects Mycoses 46(Suppl): 28-31
Bhalaria, M.K.; Naik, S.; Misra, A.N. 2009: Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases Indian Journal of Experimental Biology 47(5): 368-375
Tiewcharoen, S.; Junnu, V.; Suvoutho, S. 2003: Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources Journal of the Medical Association of Thailand 86(9): 876-882
Cammarata, E.; Minardi, R.; Oliveri, S. 1997: Relative inhibition index of antifungal drugs by diffusion agar susceptibility test Bollettino della Societa Italiana di Biologia Sperimentale 73(7-8): 107-114
Ablordeppey, S.Y.; Fan, P.; Ablordeppey, J.H.; Mardenborough, L. 1999: Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development Current Medicinal Chemistry 6(12): 1151-1195
Silvestri, R.; Pagnozzi, E.; Troccoli, F.; Stefancich, G.; Massa, S.; Apuzzo, G.; Perazzi, M.E.; Artico, M.; Simonetti, G. 1995: Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives Farmaco 50(4): 227-238
Massa, S.; Stefancich, G.; Corelli, F.; Silvestri, R.; Panico, S.; Artico, M.; Simonetti, N. 1988: Researches on antibacterial and antifungal agents. IX--Pyrrole analogues of bifonazole with potent antifungal activities Il Farmaco; Edizione Scientifica 43(9): 693-704
Uchida, K.; Hosaka, J.; Aoki, K.; Yamaguchi, H. 1991: In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses Japanese Journal of Antibiotics 44(5): 571-579
Corelli, F.; Massa, S.; Stefancich, G.; Mai, A.; Artico, M.; Panico, S.; Simonetti, N. 1987: Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin a Il Farmaco; Edizione Scientifica 42(12): 893-903
Frisk, M.; Strömstedt, A. 2000: Choice of drugs--by whom, for whom and to what costs? Lakartidningen 97(39): 4343-4346
Rise, L. 2003: The costs of drugs against ADDH should be reduced Lakartidningen 100(26-27): 2316;AuthorReply 2316
Poikolainen, K. 1998: Drugs in Finland: occurrence and costs Duodecim; Laaketieteellinen Aikakauskirja 114(20): 2103-2108